Literature DB >> 1688873

Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride.

M A Wainberg1, B Spira, G Bleau, R Thomas.   

Abstract

We have shown that the spermicidal agent benzalkonium chloride can exert a direct inhibitory effect on the viral reverse transcriptase activity of human immunodeficiency virus type 1 (HIV-1) when utilized at concentrations of 0.05% and higher. Exposure of HIV-1 to this disinfectant at concentrations of more than 0.05% was able to completely destroy viral infectivity, as assessed on susceptible target cells. We have further shown that HIV-1, which is present in both seminal and genital secretions, can be inactivated in such fluids by direct exposure to benzalkonium chloride.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688873      PMCID: PMC269562          DOI: 10.1128/jcm.28.1.156-158.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

2.  Use effectiveness of a spermicidal suppository containing benzalkonium chloride.

Authors:  F Méndez; A Castro; A Ortega
Journal:  Contraception       Date:  1986-10       Impact factor: 3.375

3.  In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9.

Authors:  B Polsky; P A Baron; J W Gold; J L Smith; R H Jensen; D Armstrong
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

4.  Antimicrobial activity and physico-chemical properties of some alkyldimethylbenzylammonium chlorides.

Authors:  N N Daoud; N A Dickinson; P Gilbert
Journal:  Microbios       Date:  1983

5.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

6.  [Real and false risks of local contraception: spermicides and the diaphragm].

Authors:  M M Zufferey
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  1985

7.  Detection of human immunodeficiency virus by reverse transcriptase assay, antigen capture assay, and radioimmunoassay.

Authors:  P Gupta; R Balachandran; K Grovit; D Webster; C Rinaldo
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

8.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

  9 in total
  7 in total

Review 1.  Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review.

Authors:  L C d'Oro; F Parazzini; L Naldi; C La Vecchia
Journal:  Genitourin Med       Date:  1994-12

2.  Effect of betulinic acid and its ionic derivatives on M-MuLV replication.

Authors:  Jasmine Phillips; Iesha Phillips; Blessing Enya; Hua Zhao; Takayuki Nitta
Journal:  Biochem Biophys Res Commun       Date:  2018-04-21       Impact factor: 3.575

3.  Bile salts: natural detergents for the prevention of sexually transmitted diseases.

Authors:  B C Herold; R Kirkpatrick; D Marcellino; A Travelstead; V Pilipenko; H Krasa; J Bremer; L J Dong; M D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

4.  Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group.

Authors:  P Msellati; N Meda; V Leroy; R Likikouët; P Van de Perre; M Cartoux; D Bonard; A Ouangre; P Combe; L Gautier-Charpentier; F Sylla-Koko; R Lassalle; M Dosso; C Welffens-Ekra; F Dabis; L Mandelbrot
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

5.  Lack of evidence for transmission of human immunodeficiency virus through vaginal intercourse.

Authors:  S Brody
Journal:  Arch Sex Behav       Date:  1995-08

6.  15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery.

Authors:  L Mandelbrot; P Msellati; N Meda; V Leroy; R Likikouët; P Van de Perre; L Dequae-Merchadoux; F Sylla-Koko; A Ouangre; T Ouassa; R Ramon; L Gautier-Charpentier; M Cartoux; M Dosso; F Dabis; C Welffens-Ekra
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

7.  Commentary: methods women can use that may prevent sexually transmitted disease, including HIV.

Authors:  M J Rosenberg; E L Gollub
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.